Liberia vs Togo: Population requiring preventive chemotherapy for schistosomiasis
Liberia
2.49 million
in 2024
Togo
3.19 million
in 2024
Liberia rank
28th
Togo rank
25th
Population requiring preventive chemotherapy for schistosomiasis over time
- Liberia
- Togo
How they compare
Togo currently reports 3.19 million against 2.49 million in Liberia, a difference of 704,060.
That makes Togo's figure about 1.3 times Liberia's.
Across all 15 years both countries report, Togo has been ahead every year.
Liberia ranks 28th and Togo ranks 25th of 52 countries.
Togo has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Liberia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.12 million | 2.69 million | 1.56 million | Togo |
| 2020s | 1.42 million | 3.39 million | 1.98 million | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Liberia or Togo?
- Togo, at 3.19 million against 2.49 million in Liberia as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Liberia and Togo?
- 704,060, with Togo ahead.
- How many years of comparable data are there for Liberia and Togo?
- 15 years are reported by both, from 2010 to 2024.
- How do Liberia and Togo rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Liberia ranks 28th and Togo ranks 25th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.